Followers | 118 |
Posts | 10318 |
Boards Moderated | 1 |
Alias Born | 11/27/2015 |
Thursday, October 11, 2018 7:38:09 PM
I am expecting a huge amount of investors to this board in the next couple of weeks so I wanted to give you an easy list of all the useful links you may want to know.
Here is a quick link to Oncbiomunes' Pipeline:
http://oncbiomune.com/pipeline/
Here is a quick link to the latest press releases:
http://oncbiomune.com/news/
Proscavax has the most potential in the pipeline and will be starting Phase 2 clinical trials at BIDMC (Harvard Medical) and UCNT (Urinary Clinic of North Texas):
https://clinicaltrials.gov/ct2/show/NCT02058680?term=oncbiomune&rank=2
https://clinicaltrials.gov/ct2/show/NCT03579654
Soon the study will be listed here:
https://www.bidmc.org/centers-and-departments/cancer-center/cancer-center-programs-and-services/genitourinary-cancer-program/genitourinary-cancer-clinical-trials
and Possibly here:
https://urologyclinics.com/about_us/clinical.html#!/study/47
If you would like to check out their patents check out this message with links:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142315563
They were listed at OTCQB, but due to acquiring and then retracting a deal with Vitel this resulted in a most likely temporary downgrade to Pink, I'm expecting the up-listing back to OTCQB soon.
https://www.otcmarkets.com/stock/OBMP/overview
Hopefully everyone does their own DD as well and can see the value and potential that I see in this.
GO OBMP$
$OBMP
$OBMP
$OBMP
Recent THER News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:29:33 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 08:35:09 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 02/15/2024 10:28:54 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 08:00:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:10:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:28:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2024 11:17:03 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 12/29/2023 04:26:15 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 09:51:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 08:08:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 08:46:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/29/2023 08:01:16 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM